There are errors in the "Hemoglobin (mmol/L)" values in [Table 1](#pone.0200226.t001){ref-type="table"}, [Table 2](#pone.0200226.t002){ref-type="table"} and [Table 3](#pone.0200226.t003){ref-type="table"}. Please see the corrected tables here.

10.1371/journal.pone.0200226.t001

###### Main Baseline characteristics according to dialysis modality.

![](pone.0200226.t001){#pone.0200226.t001g}

                                                                 PD[^a^](#t001fn002){ref-type="table-fn"} patients   HD[^b^](#t001fn003){ref-type="table-fn"} patients   p
  -------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ---------
  Males (%)                                                      137 (58)                                            146 (61.8)                                          0.45
  Age (years)                                                    52 \[42;63\]                                        55 \[43;63\]                                        0.11
  Smoker (former/current) (%)                                    135 (57)                                            137 (58)                                            0.92
  Diabetes (%)                                                   43 (18.1)                                           43 (18.1)                                           1
  Hypertension (%)                                               219 (92.4)                                          199 (84)                                            0.007
  Dyslipidemia (%)                                               153 (64.6)                                          123 (47.7)                                          \<0.001
  Etiology of renal disease (%):                                                                                                                                         0.670
  Diabetic nephropathy                                           25 (10.5)                                           27 (11.4)                                           
  Vascular disease                                               23 (9.7)                                            29 (12.2)                                           
  Others                                                         189 (79.7)                                          181 (76.4)                                          
  Dialysis time (months)                                         13.7 \[6.2;28.9\]                                   14.3 \[6.41;28.6\]                                  0.91
  Body mass index (kg/m^2^)                                      26.4 \[23.3;29.2\]                                  25.3 \[23;28.6\]                                    0.23
  Systolic Blood Pressure (mmHg)                                 140 \[129;159\]                                     135 \[120;151\]                                     0.001
  Diastolic Blood Pressure (mm Hg)                               83 \[77;94\]                                        80 \[70;88\]                                        \<0.001
  Pulse Pressure (mmHg)                                          56 \[45;69\]                                        55 \[46;63\]                                        0.53
  Serum glucose (mmol/L)                                         5.05 \[2.96;6.10\]                                  5.05 \[4.56;6.10\]                                  0.838
  Urea (mmol/L)                                                  21.5 \[17.6;25.8\]                                  20.8 \[15.8;25\]                                    0.07
  Creatinine (μmol/L)                                            682.5 \[519.8;884\]                                 727.5 \[574.6;884\]                                 0.1
  Total colesterol (mmol/L)                                      4.58 \[3.99;5.20\]                                  3.91 \[3.37;4.53\]                                  \<0.001
  HDL-cholesterol (mmol/L)                                       1.22 \[1.01;1.48\]                                  1.09 \[0.90;1.29\]                                  \<0.001
  LDL-cholesterol (mmol/L)                                       2.66 \[2.07;5.15\]                                  2.07 \[1.63;2.64\]                                  \<0.001
  Triglycerides (mmol/L)                                         1.34 \[1.07;1.87\]                                  1.41 \[1.03;1.92\]                                  0.75
  Serum uric acid (μmol/L)                                       345.1 \[303.4;401.6\]                               362.9 \[321.3;425.4\]                               0.006
  hs C-Reactive Protein (nmol/L)                                 19 \[8.95;49.9\]                                    22.47 \[10.09;58.66\]                               0.23
  Albumin (mol/L)                                                0.59 \[0.54;0.62\]                                  0.59 \[0.54;0.64\]                                  0.025
  Hemoglobin (mmol/L)                                            7.2 \[7.01;8.01\]                                   7.26 \[6.70;7.76\]                                  \<0.001
  Corrected calcium (mmol/L)                                     2.3 \[2.20;2.42\]                                   2.26 \[2.16;2.36\]                                  \<0.001
  Phosphate (mmol/L)                                             1.6 \[1.35;1.84\]                                   1.54 \[1.25;1.79\]                                  0.035
  iPTH (pmolL)                                                   22.7 \[14.9;35.4\]                                  25.7 \[14.3;36.4\]                                  0.23
  25-hydroxy-vitamin D (nmol/L)                                  28.9 \[20.9;41.2\]                                  37.4 \[26.4;48.7\]                                  \<0.001
  1-25-hydroxy-vitamin D (pmol/L)                                13.6 \[9.72;19.9\]                                  13.8 \[9.31;22.3\]                                  0.54
  Treatments                                                                                                                                                             
  Antihypertensive (%):                                          214 (90.3)                                          159 (67.1)                                          \<0.001
  ACEI[^c^](#t001fn004){ref-type="table-fn"} (%)                 66 (27.8)                                           41 (17.3)                                           0.008
  ARBs[^d^](#t001fn005){ref-type="table-fn"} (%)                 111 (46.8)                                          54 (22.8)                                           \<0.001
  Diuretics (%)                                                  128 (54)                                            45 (19)                                             \<0.001
  Statins (%)                                                    137 (57.8)                                          110 (46.4)                                          0.017
  Phosphate binders (%):                                         198 (83.5)                                          189 (79.7)                                          0.343
  Binders without Ca[^e^](#t001fn006){ref-type="table-fn"} (%)   126 (53.2)                                          138(58.2)                                           0.309
  Binders with Ca[^e^](#t001fn006){ref-type="table-fn"} (%)      42 (47.2)                                           40 (47.1)                                           1
  Ca^e^ intake (binders) (gr/day)                                1.5 \[1;2\]                                         1.65 \[1;3\]                                        0.027
  Calcitriol/Paricalcitol (%)                                    97 (40.9)                                           122 (51.5)                                          0.027
  Calcifedol /%)                                                                                                                                                         
  Cholecalciferol (%)                                            27 (11.4)                                           8 (3.38)                                            0.002
  Cinacalcet (%)                                                 11(4.64)                                            8 (3.38)                                            0.640
  Antiplatelet drugs (%):                                        27 (24.1)                                           68 (28.7)                                           0.297
  ESA[^f^](#t001fn007){ref-type="table-fn"}(%)                   181(76.4)                                           198 (83.5)                                          0.066
  Renal transplantation centre (%)                               88 (37.1)                                           62 (26.2)                                           0.014
  Plaque presence (%)                                            123 (51.9)                                          143 (60.3)                                          0.08
  Number of territories with plaque                              2 \[1.0;3.0\]                                       2 \[1.0;3.0\]                                       0.285
  cIMT[^g^](#t001fn008){ref-type="table-fn"} (mm)                0.65 \[0.56;0.79\]                                  0.70 \[0.6;0.84\]                                   0.009
  Ankle-Brachial index (%)                                                                                                                                               
  ABI [\<]{.ul} 0.9                                              37 (15.7)                                           23 (9.91)                                           0.08
  ABI \>0.9-\<1.4                                                175 (74.5)                                          144 (62.1)                                          0.005
  ABI [\>]{.ul} 1.4                                              23 (9.79)                                           65 (28)                                             \<0.001

Data are presented as median \[interquartile range\], mean (standard deviation) or n(%).

^a^ Peritoneal dialysis

^b^ Hemodialysis

^c^ Angiotensin converting enzyme inhibitors

^d^ Angiotensin II receptor blockers

^e^ Calcium

^f^ Erythropoiesis stmulating agents

^g^ Common carotid artery intima media thickness

10.1371/journal.pone.0200226.t002

###### Main Baseline characteristics of patients with 2-years follow-up according to dialysis modality.

![](pone.0200226.t002){#pone.0200226.t002g}

                                                                 PD[^a^](#t002fn002){ref-type="table-fn"} patients   HD[^b^](#t002fn003){ref-type="table-fn"} patients   p
  -------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ---------
  Males (%)                                                      47 (57.3)                                           48 (52.2)                                           0.6
  Age (years)                                                    53 \[42.5;63\]                                      55 \[44.8;64\]                                      0.39
  Smoker (former/current) (%)                                    49 (59.8)                                           48 (52.2)                                           0.9
  Diabetes (%)                                                   14 (17.1)                                           14 (15.2)                                           0.9
  **Hypertension (%)**                                           75 (91.5)                                           79 (86)                                             0.359
  **Dyslipidemia (%)**                                           58 (70.7)                                           55 (59.8)                                           0.176
  Etiology of renal disease (%):                                                                                                                                         0.670
  Diabetic nephropathy                                           7 (8.54)                                            8 (8.7)                                             
  Vascular disease                                               8 (9.76)                                            13 (14.1)                                           
  Others                                                         67 (81.7)                                           71 (77.2)                                           
  Dialysis time (months)                                         10.5 \[4.46;19.2\]                                  11.5 \[5.82;25.8\]                                  0.131
  Body mass index (kg/m^2^)                                      26.4 \[23.3;28.4\]                                  26.1 \[23;4.32.2\]                                  0.446
  Systolic Blood Pressure (mmHg)                                 145 (24.4)                                          138 (21.8)                                          0.03
  Diastolic Blood Pressure (mm Hg)                               87.5 (12.2)                                         78.8 (13.3)                                         \<0.001
  Pulse Pressure (mmHg)                                          56 \[44;69\]                                        56.5 \[47;70.2\]                                    0.579
  Serum glucose (mmol/L)                                         5.16 \[4.72;5.61\]                                  5.23 \[4.55;6.05\]                                  0.931
  Urea (mmol/L)                                                  22.11 (6.76)                                        20.31 (6.13)                                        0.053
  Creatinine (μmol/L)                                            596.7 \[468.5;792.1\]                               676.3 \[583.4;837.2\]                               0.815
  Total colesterol (mmol/L)                                      4.75 \[4.2;5.43\]                                   3.9 \[3.2;4.45\]                                    0.258
  HDL-cholesterol (mmol/L)                                       1.21 \[1;1.52\]                                     1.1 \[0.88;1.21\]                                   0.005
  LDL-cholesterol (mmol/L)                                       3.46 \[2.28;3.05\]                                  3.36 \[2.56;4.4\]                                   \<0.001
  Triglycerides (mmol/L)                                         1.53 \[1.09;2.02\]                                  1.48 \[1.13;1.94\]                                  0.940
  Serum uric acid (μmol/L)                                       350.4 (72.6)                                        369.4 (70.78)                                       0.093
  hs C-Reactive Protein (nmol/L)                                 26.28 \[10;61.24\]                                  24 \[10.47;62.48\]                                  0.815
  Albumin (mol/L)                                                0.59 \[0.53;0.62\]                                  0.59 \[0.54;0.64\]                                  0.471
  Hemoglobin (mmol/L)                                            7.24 (0.80)                                         6.82 (0.84)                                         0.002
  Corrected calcium (mmol/L)                                     2.32 \[2.22;2.4\]                                   2.25 \[2.16;2.32\]                                  0.031
  Phosphate (mmol/L)                                             1.52\[1.32;1.81\]                                   1.55 \[1.29;1.81\]                                  0.965
  iPTH (pmolL)                                                   21.1 \[15.48;34.25\]                                26.51 \[16.2;41\]                                   0.182
  25-hydroxy-vitamin D (nmol/L)                                  30.5 \[21.75;43.75\]                                35.5 \[27;48\]                                      0.014
  1-25-hydroxy-vitamin D (pmol/L)                                15.45 \[10.3;22.7\]                                 14.4 \[10.15;25.75\]                                0.862
  Treatments                                                                                                                                                             
  Antihypertensive (%):                                          72 (87.8)                                           60 (65.2)                                           0.001
  ACEI[^c^](#t002fn004){ref-type="table-fn"} (%)                 20 (24.4)                                           15 (16.3)                                           0.255
  ARBs[^d^](#t002fn005){ref-type="table-fn"} (%)                 37 (45.1)                                           25 (27.2)                                           0.021
  Diuretics (%)                                                  27 (32.6)                                           28 (32.9)                                           0.837
  Statins (%)                                                    48 (58.3)                                           50 (54.3)                                           0.687
  Phosphate binders (%):                                         66 (80.5)                                           68 (73.9)                                           0.396
  Binders without Ca[^e^](#t002fn006){ref-type="table-fn"} (%)   38 (46.3)                                           48(52.2)                                            0.538
  Binders with Ca[^e^](#t002fn006){ref-type="table-fn"} (%)      42 (47.2)                                           40 (47.1)                                           1
  Ca^e^ intake (binders) (gr/day)                                1 \[1;1.5\]                                         1.5 \[1;2.5\]                                       0.03
  Calcitriol/Paricalcitol (%)                                    34 (41.5)                                           44 (47.8)                                           0.490
  Calcifedol /%)                                                 8 (9.76)                                            5 (5.43)                                            0.428
  Cholecalciferol (%)                                            2 (2.44)                                            4 (4.35)                                            0.685
  Cinacalcet (%)                                                 18 (22)                                             24 (26.1)                                           0.646
  Antiplatelet drugs (%):                                        22 (26.8)                                           27 (29.3)                                           0.842
  ESA[^f^](#t002fn007){ref-type="table-fn"} (%)                  62 (75.6)                                           77 (83.7)                                           0.255
  Renal transplantation centre (%)                               27 (32.9)                                           20 (21.7)                                           0.137
  Plaque presence (%)                                            44 (53.7)                                           53 (57.6)                                           0.711
  Number of territories with plaque                              2 \[1.0;2.0\]                                       2 \[1.0;3.0\]                                       0.149
  cIMT[^g^](#t002fn008){ref-type="table-fn"} (mm)                0.65 \[0.57;0.75\]                                  0.72 \[0.62;0.86\]                                  0.005
  Ankle-Brachial index (%)                                                                                                                                               \<0.001
  ABI [\<0.9]{.ul}                                               10 (12.2)                                           7 (7.78)                                            
  ABI \>0.9-\<1.4                                                66 (80.5)                                           55 (61.1)                                           
  ABI [\>]{.ul} 1.4                                              6 (7.32)                                            21 (31.1)                                           

Data are presented as median \[interquartile range\], mean (standard deviation) or n (%).

^a^ Peritoneal dialysis

^b^ Hemodialysis

^c^ Angiotensin converting enzyme inhibitors

^d^ Angiotensin II receptor blockers

^e^ Calcium

^f^ Erythropoiesis stimulating agents

^g^ Common carotid artery intima media thickness

10.1371/journal.pone.0200226.t003

###### Main Baseline characteristics of patients with 2-years follow-up according to dialysis modality.

![](pone.0200226.t003){#pone.0200226.t003g}

                                                                       AVD[^a^](#t003fn002){ref-type="table-fn"} progression   Non AVD progression     p
  -------------------------------------------------------------------- ------------------------------------------------------- ----------------------- -----------
  Males (%)                                                            50 (56.2)                                               45 (52.9)               0.78
  Age (years)                                                          57 \[48;65\]                                            50 \[39;62\]            0.004
  Smoker (former/current) (%)                                          53 (59.6)                                               44 (51.8)               0.38
  Diabetes (%)                                                         20 (22.5)                                               8 (9.41)                0.033
  Hypertension (%)                                                     79 (88.8)                                               75 (88.2)               1
  Dyslipidemia (%)                                                     59 (66.3)                                               54 (63.5)               0.824
  Etiology of renal disease (%):                                                                                                                       0.165
  Diabetic nephropathy                                                 25 (10.5)                                               27 (11.4)               
  Vascular disease                                                     23 (9.7)                                                29 (12.2)               
  Others                                                               69 (77.5)                                               69 (81.2)               
  Dialysis time (months)                                               10.2 \[4.4;23.2\]                                       11.8 \[6.47;22.5\]      0.27
  Body mass index (kg/m^2^)                                            27 \[23.6;30.7\]                                        26.1 \[23.1;28.8\]      0.156
  Systolic Blood Pressure (mmHg)                                       142 (24.3)                                              141 (24.3)              0.735
  Diastolic Blood Pressure (mm Hg)                                     82 (13.5)                                               83.9 (13.5)             0.343
  Pulse Pressure (mmHg)                                                60 \[44;74\]                                            56 \[45;66\]            0.326
  Serum glucose (mmol/L)                                               5.18 \[4.54;6.10\]                                      5.05 \[4.49;5.66\]      0.157
  Urea (mmol/L)                                                        18.3 (5.25)                                             18.3 (5.21)             0.984
  Creatinine (μmol/L)                                                  610 \[486.2;797.4\]                                     662.1 \[557.8;839.8\]   0.089
  Total colesterol (mmol/L)                                            4.14 \[3.63;4.89\]                                      4.45 \[3.57;5.33\]      0.258
  HDL-cholesterol (mmol/L)                                             1.10 \[0.93;1.39\]                                      1.16 \[0.96;1.37\]      0.561
  LDL-cholesterol (mmol/L)                                             2.30 \[1.85;2.82\]                                      2.61 \[1.81;2.98\]      0.264
  Triglycerides (mmol/L)                                               1.51 \[1.11;2.10\]                                      1.38 \[1.07;1.92\]      0.528
  Serum uric acid (μmol/L)                                             370.5 (72.6)                                            350.4 (70.8)            0.084
  hs C-Reactive Protein (nmol/L)                                       37.7 \[13.8;65.9\]                                      18.5 \[8.4;54.2\]       0.04
  Albumin (mol/L)                                                      0.59 \[0.0.53;0.63\]                                    0.59 \[0.54;0.62\]      0.613
  Hemoglobin (mmol/L)                                                  7 (0.95)                                                7 (0.80)                0.962
  Corrected calcium (mmol/L)                                           2.31 \[2.19;2.4\]                                       2.26 \[2.12;2.37\]      0.419
  Phosphate (mmol/L)                                                   1.52 \[1.26;1.81\]                                      1.55 \[1.36;1.84\]      0.292
  iPTH (pmolL)                                                         24.7 \[15.9;38.1\]                                      23.3 \[15.27;36.7\]     0.586
  25-hydroxy-vitamin D (nmol/L)                                        30.9 \[22.8;42.9\]                                      36.4 \[26.7;48.7\]      0.043
  1-25-hydroxy-vitamin D (pmol/L)                                      14.9 \[10.0;24.5\]                                      13.6 \[9.7;22.3\]       0.602
  Treatments                                                                                                                                           
  Antihypertensive (%):                                                68 (76.4)                                               64 (75.3)               1
  ACEI[^b^](#t003fn003){ref-type="table-fn"} (%)                       18 (20.2)                                               17 (20)                 1
  ARBs[^c^](#t003fn004){ref-type="table-fn"} (%)                       29 (32.6)                                               33 (38.8)               0.483
  Diuretics (%)                                                        27 (32.6)                                               28 (32.9)               0.837
  Statins (%)                                                          51 (57.3)                                               47 (55.3)               0.9
  Phosphate binders (%):                                               68 (76.4)                                               66 (77.6)               0.98
  Binders without Ca[^d^](#t003fn005){ref-type="table-fn"} (%)         39 (43.8)                                               47 (55.3)               0.173
  Binders with Ca[^d^](#t003fn005){ref-type="table-fn"} (%)            42 (47.2)                                               40 (47.1)               1
  Ca[^d^](#t003fn005){ref-type="table-fn"} intake (binders) (gr/day)   1 \[1;1.5\]                                             1.5 \[1;2.5\]           
  Calcitriol/Paricalcitol (%)                                          45 (50.6)                                               33 (38.8)               0.16
  Calcifedol /%)                                                       9 (10.1)                                                4 (4.71)                0.286
  Cholecalciferol (%)                                                  3 (3.37)                                                3 (3.53)                1
  Cinacalcet (%)                                                       19 (21.3)                                               23 (27.1)               0.482
  Antiplatelet drugs (%):                                              27 (30.3)                                               22 (25.9)               0.628
  ESA[^e^](#t003fn006){ref-type="table-fn"} (%)                        66 (74.2)                                               73 (85.9)               0.082
  Renal transplantation centre (%)                                     22 (24.7)                                               25 (29.4)               0.599
  Plaque at baseline (%)                                               64 (71.9)                                               33 (33.8)               \<0.001
  Number of territories with plaque                                    2 \[1.0;3.0\]                                           2 \[1.0;3.0\]           0.398
  cIMT[^f^](#t003fn007){ref-type="table-fn"} (mm)                      0.73 \[0.65;0.89\]                                      0.64 \[0.56;0.74\]      \<0.001
  Ankle-Brachial index (%)                                                                                                                             
  ABI [\<0.9]{.ul}                                                     11 (12.5)                                               6 (7.14)                0.357
  ABI \>0.9-\<1.4                                                      57 (64.8)                                               64 (76.2)               0.141
  ABI [\>]{.ul} 1.4                                                    20 (22.7)                                               14 (16.7)               0.420
  **Dialysis modality:**                                                                                                                               **0.437**
  **Hemodialysis**                                                     **44 (49.4)**                                           **48 (56.5)**           
  **Peritoneal dialysis**                                              **45 (50.6)**                                           **37 (43.5)**           

Data are presented as median \[interquartile range\], mean (standard deviation) or n (%).

^a^ Atheromatous vascular disease

^b^ Angiotensin converting enzyme inhibitors

^c^ Angiotensin II receptor blockers

^d^ Calcium

^e^ Erythropoiesis stimulating agents

^f^ Common carotid artery intima media thickness
